文献速递认知障碍与痴呆帕金森病与运动障碍

理解GBA1相关帕金森病认知衰退模式:一项探索性纵向多队列研究

Understanding the Pattern of Cognitive Decline in GBA1‐Related Parkinson's Disease: An Exploratory Longitudinal Multi‐Cohort Study
RSS 订阅 · Annals of Neurology · 2026-11-02

该探索性纵向多队列研究纳入546名健康对照、903名GBA1野生型帕金森病患者和211名GBA1突变帕金森病患者,发现GBA1突变患者在基线时执行功能、注意力、视认知技能和记忆表现更差,且衰退更快速广泛;其临床相关认知障碍风险增加,加工速度和视知觉损害分别比野生型早1.2和2.5个疾病年。

要点

  • GBA1突变帕金森病患者基线时执行功能、注意力、视认知技能和记忆均差于野生型患者。
  • GBA1突变患者认知衰退更快速且广泛,临床相关认知障碍风险增加。
  • 加工速度和视知觉在GBA1突变患者中最早受损,分别比野生型早1.2和2.5个疾病年。

核心结论

  • 与GBA1野生型帕金森病患者相比,GBA1突变帕金森病患者表现出加速的、跨认知域的且更严重的认知衰退。

研究设计与样本

  • 探索性纵向多队列研究,纳入帕金森病进展标志物倡议(PPMI)、帕金森病脑脊液β淀粉样蛋白作为认知功能障碍危险因素研究(ABC-PD)和国家帕金森病卓越研究中心的三个队列。
  • 共纳入546名健康对照(随访年数=2.9±4.3)、903名GBA1野生型帕金森病患者(随访年数=4.4±4.2)和211名GBA1突变帕金森病患者(随访年数=4.8±3.4)。
  • 采用广义线性混合效应模型(GLMM)评估各认知域表现,并进行探索性潜在轨迹分析识别认知亚组。
  • 采用至首次事件模型评估临床相关表现损害(测验分数z≤-1.5,蒙特利尔认知评估[MoCA]<26)风险,并采用扩展时间窗方法识别认知障碍进程。

主要发现

  • GBA1突变帕金森病患者在基线时执行功能、注意力、视认知技能和记忆表现均差于GBA1野生型帕金森病患者,且在这些认知域表现出更快速和广泛的衰退。
  • GBA1突变帕金森病患者在疾病过程中发生临床相关认知障碍的风险增加。
  • 在GBA1突变帕金森病患者中,加工速度和视知觉表现损害最早出现,分别比GBA1野生型帕金森病患者早1.2和2.5个疾病年。
  • 在GBA1突变帕金森病组内识别出一个认知快速衰退亚组,该亚组更可能为男性患者、报告抑郁症状并携带严重GBA1突变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective People with Parkinson's disease (PD) who carry a pathogenic GBA1 variant (PDGBA1) are at higher risk of cognitive impairment than those without the variant (PDGBA1_wildtype). To date, little is known about the pattern and evolution of cognitive decline in PDGBA1. This multicenter study characterized the cognitive profile of PDGBA, focusing on the longitudinal trajectories and the group-specific onset times among cognitive functions, as well as their clinical relevance. Methods In this exploratory longitudinal multicohort-study (Parkinson's Precision Medicine Initiative [PPMI], Amyloid-Beta in cerebrospinal spinal fluid as a risk factor for cognitive dysfunction in Parkinson's Disease [ABC-PD], and National Centre for Excellence in Research on Parkinson's disease [NCER-PD]), comprehensive neuropsychological assessments were standardized across 546 healthy controls (follow-up years = 2.9 ± 4.3), 903 PDGBA1_wildtype (follow-up years = 4.4 ± 4.2), and 211 PDGBA1 (follow-up years = 4.8 ± 3.4). We evaluated performance across age and disease duration using generalized linear mixed effects models (GLMMs) within each cognitive domain. An exploratory latent trajectory analysis was computed to identify potential cognitive subgroups. Time-to-first-event models, assessing risks of clinically relevant performance impairment (test score z ≤ −1.5, Montreal Cognitive Assessment [MoCA] < 26), and an expanding time-window approach identified the course of cognitive impairment. Results PDGBA1 performed worse in executive function, attention, visuocognitive skills, and memory than PDGBA1_wildtype at baseline and exhibited a more rapid and widespread decline across these domains. The risk of developing clinically relevant cognitive impairment during the disease course was increased in PDGBA1. Processing speed and visuoperceptual showed the earliest performance impairments in PDGBA1, preceding PDGBA1_wildtype by 1.2 and 2.5 disease years, respectively. Within the PDGBA1 group, we identified a subgroup with rapidly declining cognition, who were more likely to be male patients, report depressive symptoms, and carry a severe GBA1 mutation. Interpretation PDGBA1 exhibits accelerated domain-generalized and more severe cognitive decline compared to PDGBA1_wildtype. ANN NEUROL 2026

来源:Annals of Neurology,查看原文。版权归原作者所有。

引用

  1. Annals of Neurology:Understanding the Pattern of Cognitive Decline in GBA1‐Related Parkinson's Disease: An Exploratory Longitudinal Multi‐Cohort Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。